NutriBand (NTRB) EBIT (QoQ) (2016 - 2026)
NutriBand (NTRB) EBIT (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | NutriBand | 48.38 Mn | 44.37 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -22.87% |
| Jan 31, 2026 | 73.69% |
| Oct 31, 2025 | -93.71% |
| Jul 31, 2025 | -41.72% |
| Apr 30, 2025 | 74.57% |
| Jan 31, 2025 | -289.59% |
| Oct 31, 2024 | -1.21% |
| Jul 31, 2024 | 25.39% |
| Apr 30, 2024 | -44.64% |
| Jan 31, 2024 | 24.20% |
| Oct 31, 2023 | -109.12% |
| Jul 31, 2023 | 19.03% |
| Apr 30, 2023 | 39.54% |
| Jan 31, 2023 | -57.12% |
| Oct 31, 2022 | -3.60% |
| Jul 31, 2022 | -50.79% |
| Apr 30, 2022 | 81.83% |
| Jan 31, 2022 | -145.38% |
| Oct 31, 2021 | -219.02% |
| Jul 31, 2021 | -53.55% |